ORKA

Oruka Therapeutics (ORKA)

About Oruka Therapeutics (ORKA)

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Details

Daily high

$33.43

Daily low

$31.38

Price at open

$32.03

52 Week High

$36.51

52 Week Low

$5.48

Market cap

1.6B

Dividend yield

0.00%

Volume

504,899

Avg. volume

489,283

P/E ratio

-13.67

Oruka Therapeutics News